SMA News Today publishes a series of articles on Evrysdi discovery and development
September 20, 2020
In August, SMA News Today published a series of articles on the discovery and development of Evrysdi, the first and only oral medicine for SMA approved by the FDA. The articles cover a range of topics including the role of the SMA Foundation in drug development, the experiences of patients taking Evrysdi, and the future of SMA therapeutics. Please see below for links to the articles.